NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
The Latest on: Fecal microbiota transplantation
via Google News
The Latest on: Fecal microbiota transplantation
- ADVENTURES IN FOOD AND FITNESS: Fecal transplants help Fort Wayne patients suffering from deadly diarrheaon January 18, 2021 at 4:00 pm
You must be exceptionally fit — inside and out – to provide material for the process known as fecal microbial transplant (FMT), in which stool containing desirable gut bacteria is inserted ...
- The microbiota in pneumonia: From protection to predispositionon January 15, 2021 at 6:46 pm
Bacterial density and complexity increase along the gastrointestinal tract, but the gut microbiota has been mainly characterized by examining stool specimens from rodents and humans. In healthy adult ...
- Alteration of the Intestinal Microbiomeon January 14, 2021 at 4:00 pm
In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT) is a highly effective treatment option promoting the restoration of normal gut microbiota. Furthermore, preliminary ...
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantationon January 13, 2021 at 4:00 pm
The microbiota composition of fecal samples obtained from patients who were undergoing allogeneic hematopoietic-cell transplantation at four centers was profiled by means of 16S ribosomal RNA gene ...
- The Gut Microbiome in GI Diseases: How and When to Manipulate It?on January 13, 2021 at 2:20 am
Fecal Microbial Transplantation Faecal microbial transplantation has been effectively used in people for treatment of C. difficile infection. The benefits of FMT are probably not limited to the actual ...
- Fecal Transplants Safe Long Term for Recurrent C. Diffon January 12, 2021 at 2:00 pm
More evidence has emerged for fecal microbiota transplantation (FMT) as a safe option for treating recurrent Clostridioides difficile infection (CDI), according to a survey-based study.
- Poor gut health connected to severe COVID-19, new review showson January 12, 2021 at 3:03 am
Eating more fiber, he said, may lower a person's risk of serious disease. And fecal microbiota transplantation might be a treatment worth considering for patients with the worst cases of COVID-19.
- New Research Shows Poor Gut Health Connected to Severe COVID-19 – Probiotics May Help Patientson January 12, 2021 at 3:03 am
Severe cases of COVID-19 often include GI symptoms Chronic diseases associated with severe COVID-19 are also associated with altered gut microbiota A growing body of evidence suggests poor gut health ...
- A Gut Feeling about Body Weighton January 5, 2021 at 11:56 am
Some scientists have cut right to the chase in humans, testing whether it’s possible to slim down by “resetting” the gut microbial community through fecal microbiota transplantation, transferring a ...
via Bing News